Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-010063
Filing Date
2017-04-12
Accepted
2017-04-12 16:30:31
Documents
2
Period of Report
2017-04-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6782
2 EX-24 DOCUMENT attachment1.htm EX-24 3020
  Complete submission text file 0000899243-17-010063.txt   11323
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYTODYN INC. 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address
Kelly Scott A. (Reporting) CIK: 0001703394 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-49908 | Film No.: 17758278